Correspondence 0001213900-23-008443 from BIMI Holdings Inc. (BIMI) (CIK 0001213660)
BIMI Holdings Inc. (BIMI) (CIK 0001213660)
Date: Feb. 6, 2023 · CIK: 0001213660 · Accession: 0001213900-23-008443
AI Filing Summary & Sentiment
File numbers found in text: 001-34890
Referenced dates: January 24, 2023
Letter
Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services Form 10-K for the Fiscal Year Ended December 31, 2021 Amendment No. 1 to Form 10-K Filed August 31, 2022 Form 10-Q for the Quarterly Period Ended September 30, 2022 File No. 001-34890
Dear Ms. Beukenkamp,
Pursuant to our telephone conversation today, we are confirming with this correspondence, as you requested, our understanding that you granted an extension to file BIMI International Medical Inc.’s response to the SEC comment letter dated January 24, 2023, through February 23, 2023.
If you need any additional information, please do not hesitate to contact me.
Best regards,
/s/ Pang Zhang-Whitaker
Show Raw Text
CORRESP
1
filename1.htm
Pang Zhang-Whitaker
Partner
28 Liberty Street
zhang@clm.com
New York, NY 10005
D / 212-238-8844
February 6, 2023
Ms. Kate Beukenkamp
Securities and Exchange Commission
Division of Corporation Finance
Office of Trade & Services
Re: BIMI International Medical Inc.
Form 10-K for the Fiscal Year Ended December 31, 2021
Amendment No. 1 to Form 10-K Filed August 31, 2022
Form 10-Q for the Quarterly Period Ended September
30, 2022
File No. 001-34890
Dear Ms. Beukenkamp,
Pursuant to our telephone conversation today, we are
confirming with this correspondence, as you requested, our understanding that you granted an extension
to file BIMI International Medical Inc.’s response to the SEC comment letter dated January 24, 2023, through February 23, 2023.
If you need any additional
information, please do not hesitate to contact me.
Best regards,
/s/ Pang Zhang-Whitaker
Name: Pang Zhang-Whitaker
Carter Ledyard & Milburn LLP /
clm.com